HK Stock Exchange reckons the deal is a reverse takeover.My understanding is this adds to the timetable for Dingyi very substantially.http://www.hkexnews.hk/listedco/listconews/SEHK/2013/1218/LTN20131218027.pdf
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025